<?xml version="1.0" encoding="UTF-8"?>
<EmailTemplate xmlns="http://soap.sforce.com/2006/04/metadata">
    <available>true</available>
    <description>BMS ACN - Q3 GRM 2016 - Email Template for new TSR Form - EMEA</description>
    <encodingKey>ISO-8859-1</encodingKey>
    <letterhead>BMS_Letterhead</letterhead>
    <name>BMS EMEA MSM Trial Scope Report HTML</name>
    <style>freeForm</style>
    <subject>Clinical Study Visit Report - {!Trial_Scope_Report_BMS__c.Clinical_Trial_Protocol_BMS__c} - {!Trial_Scope_Report_BMS__c.Date_BMS__c}</subject>
    <textOnly>Clinical Trial Site: {!Trial_Scope_Report_BMS__c.Clinical_Trial_Site_BMS__c}
Date: {!Trial_Scope_Report_BMS__c.Date_BMS__c}
Principle Investigator &amp; Location: {!Trial_Scope_Report_BMS__c.Principal_Investigator_Location_BMS_EMEA__c}
MSM: {!Trial_Scope_Report_BMS__c.OwnerFullName}

Question 1
Details of topics discussed during visit: {!Trial_Scope_Report_BMS__c.Q2_EU_TSR_BMS_EMEA__c}

Question 2
Were additional trainings required? {!Trial_Scope_Report_BMS__c.Q3_1_EU_TSR_BMS_EMEA__c}
If yes, select the additional trainings: {!Trial_Scope_Report_BMS__c.Q3_EU_TSR_BMS_EMEA__c}
Additional Comments: {!Trial_Scope_Report_BMS__c.Q3_Comments_EU_TSR_BMS_EMEA__c}

Question 3
Have competing trials been identified?{!Trial_Scope_Report_BMS__c.Q4_EU_TSR_BMS_EMEA__c}
If yes, provide details: {!Trial_Scope_Report_BMS__c.Q4_Comments_EU_TSR_BMS_EMEA__c}

Question 4
Any recruitment barriers identified? {!Trial_Scope_Report_BMS__c.Q6_EU_TSR_BMS_EMEA__c}
If yes, provide details:{!Trial_Scope_Report_BMS__c.Q6_Comments_EU_TSR_BMS_EMEA__c}

Question 5
Describe follow-up actions needed:{!Trial_Scope_Report_BMS__c.Q9_EU_TSR_BMS_EMEA__c}

Question 6
Names of site staff/CRO/RCO: {!Trial_Scope_Report_BMS__c.Q10_EU_TSR_BMS_EMEA__c}

Additional Comments
{!Trial_Scope_Report_BMS__c.Q11_EU_TSR_BMS_EMEA__c}</textOnly>
    <type>html</type>
</EmailTemplate>
